Linezolid versus Vancomycin for the Treatment of Methicillin‐ResistantStaphylococcus aureusInfections
Top Cited Papers
Open Access
- 1 June 2002
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (11), 1481-1490
- https://doi.org/10.1086/340353
Abstract
Linezolid, the first available member of a new antibiotic class, the oxazolidinones, is broadly active against gram-positive bacteria, including drugKeywords
This publication has 54 references indexed in Scilit:
- Bacteremia Caused by Staphylococci with Inducible Vancomycin HeteroresistanceClinical Infectious Diseases, 1999
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999
- Determinants of Vancomycin Use in Adult Intensive Care Units in 41 United States HospitalsClinical Infectious Diseases, 1999
- Bird's-eye view of nosocomial infections in medical ICUCritical Care Medicine, 1999
- The Economic Impact of Staphylococcus aureus Infection in New York City HospitalsEmerging Infectious Diseases, 1999
- Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsJournal of Medicinal Chemistry, 1996
- Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?Diagnostic Microbiology and Infectious Disease, 1994
- Methicillin-ResistantStaphylococcus aureus in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Community-acquired methicillin-resistant Staphylococcus aureus infections in childrenThe Pediatric Infectious Disease Journal, 1989
- Health and Economic Impacts of Antimicrobial ResistanceClinical Infectious Diseases, 1987